Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Tryptamine Therapeutics ( (AU:TYP) ).
Tryptamine Therapeutics Limited has announced an update related to the proposed issue of securities, adjusting the date of the Extraordinary General Meeting (EGM) and the subsequent proposed issue date. This update reflects a significant procedural adjustment, which may affect the company’s financial planning and stakeholder expectations.
More about Tryptamine Therapeutics
YTD Price Performance: 7.89%
Average Trading Volume: 1,842,510
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$52.33M
Learn more about TYP stock on TipRanks’ Stock Analysis page.
